These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence. Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863 [TBL] [Abstract][Full Text] [Related]
10. Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes. Affolter A; Liebel K; Tengler L; Seiz E; Tiedtke M; Azhakesan A; Schütz J; Theodoraki MN; Kern J; Ruder AM; Fleckenstein J; Weis CA; Bieback K; Kramer B; Lammert A; Scherl C; Rotter N; Ludwig S Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503786 [TBL] [Abstract][Full Text] [Related]
11. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer. Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374 [TBL] [Abstract][Full Text] [Related]
12. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma. Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461 [TBL] [Abstract][Full Text] [Related]
13. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma. Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925 [TBL] [Abstract][Full Text] [Related]
14. Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients. Theodoraki MN; Laban S; Jackson EK; Lotfi R; Schuler PJ; Brunner C; Hoffmann TK; Whiteside TL; Hofmann L Br J Cancer; 2021 Dec; 125(12):1677-1686. PubMed ID: 34642463 [TBL] [Abstract][Full Text] [Related]
16. Treatment dependent impact of plasma-derived exosomes from head and neck cancer patients on the epithelial-to-mesenchymal transition. Hofmann L; Waizenegger M; Röth R; Schmitteckert S; Engelhardt D; Schuler PJ; Laban S; Hoffmann TK; Brunner C; Theodoraki MN Front Oncol; 2022; 12():1043199. PubMed ID: 36686733 [TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer. Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240 [TBL] [Abstract][Full Text] [Related]
18. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495 [TBL] [Abstract][Full Text] [Related]
19. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623 [TBL] [Abstract][Full Text] [Related]
20. [Advances in salivary exosomal miRNAs in head and neck squamous carcinoma]. He J; Yang L Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):261-266. PubMed ID: 38433699 [No Abstract] [Full Text] [Related] [Next] [New Search]